包装: | 500ug |
规格: | 98% |
市场价: | 11779元 |
分子量: | 522.8 |
Background:
Fusidic acid-d6is intended for use as an internal standard for the quantification of fusidic acid by GC- or LC-MS. Fusidic acid is a fusidane antibiotic originally isolated fromF. coccineum.1It is active against the Gram-positive bacteriaS. aureus,S. pyogenes,C. diphtheriae,B. subtilis, andC. tetani(MIC50s = 0.01-20 µg/ml) but not the Gram-negative bacteriaE. coli,S. typhimurium, andP. vulgarisor the fungiC. albicansandA. fumigatus(MIC50s = >100 µg/ml for all).2Fusidic acid inhibits ribosomal recycling and protein translocation, processes mediated by elongation factor G (EF-G), in isolatedE. coliribosomes (IC50s = ~0.1 and ~200 µM, respectively).3Topical administration of fusidic acid (2%) reduces the number of skin colony forming units (CFUs) and levels of TNF-α and IL-6 in a mouse model of methicillin-resistantS. aureus(MRSA) skin wound infection.4
1.Verbist, L.The antimicrobial activity of fusidic acidJ. Antimicrob. Chemother.25(Suppl. B)1-5(1990) 2.Godtfredsen, W.O., Jahnsen, S., Lorck, H., et al.Fusidic acid: A new antibioticNature193987(1962) 3.Savelsbergh, A., Rodnina, M.V., and Wintermeyer, W.Distinct functions of elongation factor G in ribosome recycling and translocationRNA15(5)772-780(2009) 4.Mohamed, M.F., and Seleem, M.N.Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infectionDrug Des. Devel. Ther.81979-1983(2014)